Sana Biotechnology, Inc.
NASDAQ: SANA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Steven D. Harr
- Employees
- 194
- Headquarters
- Seattle, United States
- IPO year
- 2021
- Market cap
- $912.8M
- Website
- https://www.sana.com
Loading SANA…
Loading profile data…Frequently asked questions about SANA
What does Sana Biotechnology, Inc. (SANA) do?
Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases,...
Where does SANA trade?
Sana Biotechnology, Inc. (SANA) trades on the NASDAQ Global Select.
What sector is SANA in?
Sana Biotechnology, Inc. (SANA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sana Biotechnology, Inc.?
Steven D. Harr is the chief executive officer of Sana Biotechnology, Inc. (SANA).
Where is Sana Biotechnology, Inc. headquartered?
Sana Biotechnology, Inc. is headquartered in United States.
Does SANA pay a dividend?
Sana Biotechnology, Inc. (SANA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SANA go public?
Sana Biotechnology, Inc. (SANA) completed its initial public offering in 2021.